Other
Remainder of Fiscal Year 2025
Amgen Remainder of Fiscal Year 2025 increased by 200.0% to $2.7B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.9%, from $3.1B to $2.7B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2016
Last reportedQ1 2026Apr 30, 2026
Metric ID:
remainder_2025Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.2B | $600M | $1.9B | $1.3B | $600M | $2.1B | $1.4B | $700M | $3.6B | $2.4B | $1.2B | $3.1B | $2B | $900M | $2.7B |
| QoQ Change | — | -50.0% | +216.7% | -31.6% | -53.8% | +250.0% | -33.3% | -50.0% | +414.3% | -33.3% | -50.0% | +158.3% | -35.5% | -55.0% | +200.0% |
| YoY Change | — | — | — | +8.3% | +0.0% | +10.5% | +7.7% | +16.7% | +71.4% | +71.4% | +71.4% | -13.9% | -16.7% | -25.0% | -12.9% |
Range$600M – $3.6B
CAGR+26.1%
Avg YoY Growth+15.8%
Median YoY Growth+8.0%
Remainder of Fiscal Year 2025 at Other Companies
Frequently Asked Questions
- What is Amgen's remainder of fiscal year 2025?
- Amgen (AMGN) reported remainder of fiscal year 2025 of $2.7B in Q1 2026.
- How has Amgen's remainder of fiscal year 2025 changed year-over-year?
- Amgen's remainder of fiscal year 2025 decreased by 12.9% year-over-year, from $3.1B to $2.7B.